Accessible HIV Prevention
Lenacapavir is a new injectable drug made by Gilead that is highly effective at both treating and preventing HIV. Gilead recently struck a deal with The Global Fund to provide Lenacapavir for 3 million people by 2028. This deal is incredible, and it will save a lot of lives. But it also leaves out many lower- and middle-income countries where HIV is on the rise and tuberculosis is more prevalent. To fill that gap, Doctors Without Borders (Médecins Sans Frontières/MSF) tried to buy Lenacapavir from Gilead directly, but Gilead refused.
